Volumetric spline-based Kolmogorov-Arnold architectures surpass CNNs, vision transformers, and graph networks for Parkinson's disease detection

基于体积样条的 Kolmogorov-Arnold 架构在帕金森病检测方面优于卷积神经网络 (CNN)、视觉变换器和图网络。

阅读:1

Abstract

BACKGROUND: Parkinson's Disease diagnosis remains challenging due to subtle early brain changes. Deep learning approaches using brain scans may assist diagnosis, but optimal architectures remain unclear. This study applies Convolutional Kolmogorov-Arnold Networks (ConvKANs), which use flexible mathematical functions for feature extraction, to classify Parkinson's Disease from structural brain scans. METHODS: We implemented the first three-dimensional ConvKAN architecture for medical imaging and compared performance against established deep learning models, including Convolutional Neural Networks, Vision Transformers, and Graph Convolutional Networks. Three publicly available datasets containing brain scans from 142 participants (75 with Parkinson's Disease, 67 healthy controls) were analyzed. Models were evaluated using both two-dimensional brain slices and complete three-dimensional volumes, with performance assessed through cross-validation and independent dataset testing. RESULTS: Here we show that two‑dimensional ConvKAN achieved an AUC of 0.973 for Parkinson's‑disease detection, outperforming a pretrained ResNet (AUC 0.878, p = 0.047). On the early‑stage PPMI hold‑out set, the three‑dimensional variant generalised better than the two‑dimensional model (AUC 0.600 vs 0.378, p = 0.013). Furthermore, ConvKAN required 97% less training time than conventional CNNs while maintaining superior accuracy. CONCLUSIONS: ConvKAN architectures offer promising improvements for Parkinson's Disease detection from brain scans, particularly for early-stage cases where diagnosis is most challenging. The computational efficiency and strong performance across diverse datasets suggest potential for clinical implementation. These findings establish a framework for artificial intelligence-assisted diagnosis that could support earlier detection and intervention in Parkinson's Disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。